Disclosure 0001193125-26-401327-2

SEC FORM 4

$122,238.33

Tango Therapeutics, Inc. (TNGX)

Sale of 5,100 shares at $23.9683 per share.

Reporting Person Newcomb Jessica · Officer Title Principal Accounting Officer · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401327 · filed 2026-09-24 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Tango Therapeutics, Inc. (TNGX)." Disclosed 2026-09-24. https://desqlong.com/cards/0001193125-26-401327-2 (retrieved 2026-09-26).